| AD | Alzheimer’s Disease |
| ADHD | Attention Deficit Hyperactivity Disorder |
| ASR | Artifact Subspace Reconstruction |
| BART | Balloon Analogue Risk Task |
| BPRS | Brief Psychiatric Rating Scale |
| CDSS | Calgary Depression Scale for Schizophrenia |
| ESRD | End-Stage Renal Disease |
| FASTER | Fully Automated Statistical Thresholding for eeg artifact Rejection |
| FEP | First Episode Psychosis |
| GFP | Global Field Power |
| GMD | Global Map Dissimilarity |
| HC | Healthy Controls |
| ICA | Independent Component Analysis |
| MCCB | MATRICS Cognitive Consensus Battery |
| MCI | Mild Cognitive Impairment |
| MIS | Malnutrition-Inflammation Score |
| MMSE | Mini-Mental State Examination |
| MoCA | Montreal Cognitive Assessment |
| PANSS | Positive and Negative Syndrome Scale |
| PD | Parkinson’s Disease |
| qEEG | Quantitative Electroencephalography |
| RAVLT | Rey Auditory Verbal Learning Test |
| SARA | Statistical Artifact Rejection Algorithm |
| SIPS | Structured Interview for Prodromal Syndromes |
| SNR | Signal-to-noise ratio |
| UHR-NT | Ultra High-Risk Non-Transition |
| UHR-T | Ultra High-Risk Transition |
| UPDRS-III | Uniform Parkinson’s Disease Rating Scale-iii |